FIGURE

Fig. 4

ID

ZDB-FIG-250311-125

Publication

Ni et al., 2025 - Oxymatrine, a novel TLR2 agonist, promotes megakaryopoiesis and thrombopoiesis through the STING/NF-κB pathway

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

Oxymatrine accelerates platelet recovery in acute X-ray irradiated mice. (A) The strategies of establishing the irradiated mice and treatment of each groups. (B) Peripheral platelet level of control group, thrombopoietin (TPO)-treated group (3000 U/kg), oxymatrine-treated group (20 mg/kg), and model group. Histology analysis was performed on days 0, 4, 7, 10, and 12 (n = 6 per group). (C) Mean platelet volume (MPV) values in each groups (n = 6 per group). (D) Leukocyte counts in each group (n = 6 per group). (E) Erythrocyte counts in each group (n = 6 per group). (F) Flow cytometry analysis of expression of CD41 and CD61 in peripheral blood (PB) platelets in each group after treatment for 12 days. (G) The histogram exhibits the percentage of expression of CD41+/CD61+ in PB cells in each group (n = 3 per group). Data represent the mean � standard deviation (SD). Two-way analysis of variance (ANOVA) with Tukey's multiple comparisons test was used unless otherwise specified. ?P < 0.05, ??P < 0.01, and ???P < 0.001 vs. the corresponding model group. IR: ionizing radiation; FITC: fluorescein isothiocyanate; UL: upper left; UR: upper right; LL: lower left; LR: lower right.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J Pharm Anal